Next Ground-Breaking Treatment For Diabetes by Sernova Corp.
Nearly a hundred years following the discovery of insulin, Sernova produce groundbreaking treatment of type one diabetes. Their implantable cell pouch system received FDA clearance and is initiating clinical trials in the US.
Sernova is a clinical-stage company and they create useful products. Company developing products for the treatment of chronic debilitating diseases and we are using therapeutic cells transplanted into an implanted medical device called Cell Pouch™. The Cell Pouch™ forms is a natural environment for the long-term survival and function of the therapeutic cells. It release needed proteins or hormones. The company’s first products are for the treatment of insulin-dependent diabetes so all products are very usefull.
Sernova’s Cell Pouch™, combined with its Sertolin™ local immune protection technology and offers therapeutic cells local protection from immune system attack. They creating an effective and convenient therapeutic option for patients because with chronic disease they improve their quality of life.
For more information on Sernova Corp. (SVA:TSX.V) please fill out the form below.